Equibles does not estimate personal net worth.
Get an email with a short summary when Corcept Therapeutics Inc publishes a filing, an earnings call transcript or a press release.
Get CORT alertsJoe Belanoff is recorded as CEO at Corcept Therapeutics Inc (CORT). Joe Belanoff has spoken on 7 earnings calls across 1 company, most recently for Corcept Therapeutics Inc on November 3, 2026. Corcept Therapeutics Inc is classified in the Biotechnology industry within the Healthcare sector. Other leadership on record at Corcept Therapeutics Inc includes Joseph K. Belanoff (CEO and Board Member), James N. Wilson (Chairman and Board Member), Atabak Mokari (CFO) and 7 others.
“Since our founding, Corset has worked to discover and develop molecules that harness glucocorticoid receptor, GR antagonism, to treat serious diseases. The potential is enormous, and we have made important progress.”
“And thank you, everyone, for joining us. Since our founding, Corsept has worked to discover and develop molecules that harness glucocorticoid receptor, GR antagonists, to treat serious diseases.”
“And thank you, everyone, for joining us this afternoon. Since CORCEP's inception, our work has had a single focus, fully exploring the potential of cortisol modulation to treat patients with serious diseases.”
“After many years dedicated to studying the potential of cortisol modulation to help patients suffering from serious diseases, we are on the cusp of a new era at Corsept.”
“This is a very exciting time at Corcept. Our development programs have generated two significant medical discoveries in hypercortisolism and oncology, paving the way for substantial revenue growth.”
Biotechnology · Healthcare
CEO
